Amgen Research Copenhagen – key reasons behind the success

In 2019, Amgen acquired the Copenhagen-based biopharmaceutical company Nuevolution, now known as Amgen Research Copenhagen (ARC). 

Now, 4 years later Alex Gouliaev, Vice President of Research looks back and shares what life science companies can expect when they invest in Denmark and what, in his perspective makes Denmark stand out.